-
Enrollment Complete for ORARIALS-01 Trial of Arimoclomol in ALS
Enrollment is complete for the Phase 3 ORARIALS-01 study investigating the effectiveness of arimoclomol for treating amyotrophic lateral sclerosis. Read more about it here.
How do you feel about this news?
Sorry, there were no replies found.
Log in to reply.